ENPP2/Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis.
Peiqiong LuoXue-Feng YuPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
Our integrative analysis suggested that genetically determined levels of circulating ENPP2/Autotaxin have a causal effect on ALD risk and are a promising drug target.